PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market
Combines PerkinElmer’s expertise in immunodiagnostic testing and state-of-the-art genomics program with EverlyWell’s consumer health offerings WALTHAM, Massachusetts, and AUSTIN, Texas – July 24, 2019 – Today, PerkinElmer, Inc. and EverlyWell, Inc. announced a new collaboration designed to accelerate innovation in and accessibility of consumer-initiated health testing, by adding PerkinElmer’s CLIA-certified and CAP-accredited lab facilities to... Read more